Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine - PubMed (original) (raw)

Editorial

Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine

Adrian Sanchez-Fdez et al. Ann Surg Oncol. 2022 Nov.

No abstract available

PubMed Disclaimer

References

    1. Sicklick JK, Kato S, Okamura R, et al. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med. 2019;25(5):744–50. 10.1038/s41591-019-0407-5. -DOI -PMC -PubMed
    1. Sicklick JK, Kato S, Okamura R, et al. Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naive study. Genome Med. 2021;13(1):155. 10.1186/s13073-021-00969-w. -DOI -PMC -PubMed
    1. Joyner MJ, Paneth N. Seven questions for personalized medicine. JAMA. 2015;314(10):999–1000. 10.1001/jama.2015.7725. -DOI -PubMed
    1. Torkamani A, Andersen KG, Steinhubl SR, Topol EJ. High-definition medicine. Cell. 2017;170(5):828–43. 10.1016/j.cell.2017.08.007. -DOI -PMC -PubMed
    1. Li Y, Xu S, Ma S, Wu M. Network-based cancer heterogeneity analysis incorporating multi-view of prior information. Bioinformatics. 2022;38(10):2855–62. 10.1093/bioinformatics/btac183. -DOI -PMC -PubMed

Publication types

MeSH terms

LinkOut - more resources